Injectable B12 may deliver better results because: Direct bloodstream access bypasses digestive absorption barriers Higher bioavailability allows for less frequent dosing Consistent therapeutic levels maintain steady benefits [6] Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing
We ensure that you receive comprehensive care and monitoring during the procedure
BPC-157 is made of 15 amino acids and has shown potential in accelerating healing, promoting tissue regeneration, and supporting overall health
In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
In preclinical studies, BPC-157 is typically dosed at 200500 mcg/kg, TB-500 at 210 mg/kg, and GHK-Cu at 13 mg/kg, administered via subcutaneous injection, intravenous infusion, or direct tissue injection depending on study design